Consensus on secondary prevention of primary liver cancer (2021 version).
10.3760/cma.j.cn501113-20210210-00082
- VernacularTitle:原发性肝癌二级预防共识（2021年版）
- Collective Name:Chinese Society of Hepatology, Chinese Medical Association
- Publication Type:Journal Article
- Keywords:
Chronic hepatitis;
Consensus;
Diagnosis;
Hepatocellular carcinoma;
Liver cirrhosis;
Prevention;
Surveillance
- MeSH:
Carcinoma, Hepatocellular/prevention & control*;
Consensus;
Gastroenterology;
Humans;
Liver Cirrhosis;
Liver Neoplasms/prevention & control*;
Mass Screening;
Secondary Prevention
- From:
Chinese Journal of Hepatology
2021;29(3):216-226
- CountryChina
- Language:Chinese
-
Abstract:
In order to standardize the effective prevention, early screening and diagnosis of the population at risk of primary liver cancer, the Chinese Society of Hepatology and Chinese Medical Association organized the relevant domestic experts to formulate the "Consensus on Secondary Prevention of Primary Liver Cancer (2021 version)," based on the basic, clinical and preventive research progress, combined with the actual situation at home and abroad, so as to provide an important basis for the prevention, screening and early diagnosis of primary liver cancer in the population of chronic liver disease.
